Want to just get omicron and get it over with? Doctors say it’s not that simple. The omicron variant is more likely than delta to re-infect individuals who previously had COVID-19. Data show the omicron variant is more transmissible than previous variants, infecting vaccinated and unvaccinated people at record rates. Examining reinfection “If someone gets…

Update (Jan. 5, 2022): An advisory panel to the Centers for Disease Control and Prevention (CDC) voted Wednesday to approve a Food and Drug Administration (FDA) decision regarding the Pfizer COVID-19 vaccine booster in kids. That decision, in part, allowed for kids aged 12-15 to get boosted. The CDC panel also said teens should get the…

Update (Jan. 17, 2022): New research from a hospital in Israel released Monday found a fourth dose of the COVID-19 vaccine only provided limited defense against the Omicron variant of the virus. The clinical trial, which looked at more than 270 medical workers who got the fourth dose of either the Pfizer or Moderna vaccines, found…

According to recent numbers from the Centers for Disease Control and Prevention, the ongoing spread of the Omicron variant of COVID-19 has lead to a massive spike in child hospitalizations. In the seven-day period from Dec. 21 to Dec. 27, 334 American children went to hospital. That’s a 58% increase compared to the previous week,…

For the second time in as many days, the Food and Drug Administration (FDA) has approved a COVID-19 pill. Thursday’s approval was for Merck’s COVID-19 pill, also known as Molnupiravir. This followed the FDA approving the Pfizer COVID-19 pill, also known as Paxlovid, on Wednesday. Unlike the Pfizer pill, which is approved for adults and…

The Food and Drug Administration (FDA) approved the Pfizer COVID-19 pill for emergency use Wednesday. The video above shows clips of the White House COVID-19 Response Team discussing the approval. This marks the first time U.S. health regulators have approved an at-home treatment for COVID-19 since the pandemic began. “This authorization provides a new tool…

South Africa’s largest private health insurer Discovery Health teamed up with the South African Medical Research Council to release new data on the Omicron variant Tuesday. South Africa was the first country to report the variant to the World Health Organization last month. According to the data, during the country’s current Omicron-fueled surge in cases:…

Both the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention CDC approved Pfizer boosters for kids 16 and 17 years old Thursday, a day after the Senate blocked the Biden administration’s vaccine mandate for businesses employing 100 or more workers. The FDA and CDC moves serve as the first to…

A day after a federal judge blocked President Joe Biden’s federal contractor COVID-19 vaccine mandate, Pfizer released data regarding the effectiveness of the company’s vaccine on fighting the Omicron variant. According to a news release from Pfizer, the data showed that while three doses of the vaccine, “neutralize the Omicron variant”, people who only got…

The news of a new COVID-19 variant had the stock market seeing red this past week, but some stocks actually got an Omicron boost while the rest of the market got spooked. #5: Stay-at-home stocks Two of the stock market’s favorite pandemic plays, Zoom and Peloton, have had a rough go with reopening. But both…